E Fund Management Co., Ltd.
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1842296
GUANGZHOU, F4
Position in PTGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$476,958
-$158,920 QoQ
Shares Held
3,891
-35.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#214
of 341 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026E Fund Management Co., Ltd. holds $66,079,043 across 109 Biotechnology names. PTGX ranks #31 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,455 | $5,690,042 | |
| 2 | ERAS |
Erasca, Inc.
|
265,381 | $4,861,779 | |
| 3 | CELC |
Celcuity Inc.
|
45,895 | $4,801,534 | |
| 4 | EYPT |
EyePoint, Inc.
|
330,774 | $4,730,068 | |
| 5 | AVBP |
ArriVent BioPharma, Inc.
|
109,328 | $3,798,054 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,158 | $3,216,219 | |
| 7 | LEGN |
Legend Biotech Corp
|
109,327 | $3,157,363 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,073 | $1,828,155 |
All Filings in PTGX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $476,958 | 3,891 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $635,878 | 6,033 | Shares | Defined | 2026-04-13 | |
| 2025-06-30 | $496,877 | 8,990 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $200,065 | 4,137 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,936,958 | 76,087 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,224,970 | 71,666 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $327,024 | 11,304 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $205,384 | 8,957 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $300,089 | 17,991 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $424,077 | 15,354 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $200,399 | 8,713 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $168,908 | 15,482 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $201,038 | 23,848 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $285,021 | 36,033 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $247,219 | 10,440 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||